Cite
HARVARD Citation
Arribas, A. et al. (n.d.). Improving responses to dual PI3K/BCL2 inhibition in lymphomas: results of a pharmacological screen with over 1, 400 compounds. European journal of cancer. pp. S107-S108. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Arribas, A. et al. (n.d.). Improving responses to dual PI3K/BCL2 inhibition in lymphomas: results of a pharmacological screen with over 1, 400 compounds. European journal of cancer. pp. S107-S108. [Online].